Skip to content

Global Promise

Insights on International Collaborative Health

Global Promise Home Health Innovation Homing In on Better Health

At Johns Hopkins, pursuing personalized medicine is nothing new. Our founding father William Osler set the course of modern medicine by urging his colleagues to “care more for the individual patient than for the special features of his disease.”

For 130 years, Johns Hopkins has focused on the idea that every patient’s battle with a disease is unique. While we are all 99.9 percent identical genetically, the differences that result from the remaining 0.1 percent make it unlikely that any two of us will respond the same way to a disease or a specific treatment.

Precision medicine holds a lot of promise for making health care more personalized and effective. As articulated by my colleagues Drs. Antony Rosen and Scott Zeger, precision medicine is the science-based application of modern measurement and analysis to improve each health decision.

This includes not only new advances in genetic testing, but also accurate and detailed clinical information to identify relevant health and disease subgroups. Our physicians can then use that information to determine what conditions we might develop, and what treatments or interventions are likely to work best for each specific patient.

At Johns Hopkins Medicine International, we connect clinical staff and investigators from our global affiliates with their Johns Hopkins counterparts to share knowledge and stimulate collaboration that will allow medical systems everywhere to achieve a new level of precision in health care.

Additionally, international patients who come to Johns Hopkins with diseases ranging from heart disease to prostate cancer are already benefiting from our advances in precision medicine and its application as innovative clinical care.

We are excited to see how we can apply precision medicine more broadly here and around the world. Learn more about the Johns Hopkins Medicine approach to personalized medicine in this special report.


Charles Wiener

President, Johns Hopkins Medicine International Professor of Medicine and Physiology, Johns Hopkins University School of Medicine Charles Wiener oversees Johns Hopkins Medicine’s international enterprises, developing sustainable, innovative collaborations that raise the standard of health care around the world and providing personalized care for diverse populations. Johns Hopkins Medicine International serves as the global ambassador of the Johns Hopkins Medicine mission, leveraging JHM’s extensive knowledge base in medicine, nursing, public health, medical education, research and health care administration to deliver the promise of medicine across the globe. Dr. Wiener previously spent three years as Johns Hopkins Medicine International’s vice president of academic affairs and vice president of Asia operations. In these roles, he led multiple global projects, including strategic planning, oversight of educational infrastructure planning and medical training. He focused on coordinating faculty involvement in advancing Johns Hopkins’ growing international collaborations. Click here to learn more about Charlie.

2 thoughts on “Homing In on Better Health”

  1. I am Augusto Saavedra, Nephrologist from private clinic Ricardo Palma in Lima, Peru (34 years). We have more than 35000 outpatient care per month, more than 300 inpatient per months, 185 hospital beds (adults, pedriatics, ICU for adults and for children’s and newly born also. Almost 200 hospital beds, 350 physicians of almost all speciality. Emergency service for adults (500-600 patients per day) and children’s also.
    We are two full-time and two part- time nephrologists; two of them under 35. We attend more or less 500 outpatients care per month. 10 - 15 inpatients in addition to interconsultations of other specialties. A small hemodialysis unit, 30-36 chronic ambulatory patients, in addition to acute patients in Emergency, hospitalization and intensive care ( adults and children). We perform biopsies but we do not always have an electron microscope study.
    We also have a Clinical Research Center, I am one of the PI there. We carry out phase III studies. The CRC has more than 10 years.
    We are very interested in to learn and development about precision medicine in our unit. We want to know what we should do.

    1. Global Promise Editor

      Thank you for interest in partnering with Johns Hopkins Medicine. We've passed along your comment and contact information to our colleagues who support affiliations in the Americas. Best to you in your research.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.